Lisanti Capital Growth’s AtriCure ATRC Stock Holding History

Lisanti Capital Growth’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-26,610	Closed	-$1.85M	–	118
2021 Q3	$1.85M	Sell	26,610 -40,360	-60%	-$3.11M	0.27%	118
2021 Q2	$5.31M	Buy	+66,970	New	+$4.87M	0.66%	67
2020 Q3	–	Sell	-135,490	Closed	-$6.09M	–	116
2020 Q2	$6.09M	Buy	135,490 +105,055	+345%	+$4.57M	1.24%	25
2020 Q1	$1.02M	Buy	+30,435	New	+$1.09M	0.34%	86
2016 Q2	–	Sell	-22,540	Closed	-$379K	–	95
2016 Q1	$379K	Buy	+22,540	New	+$397K	0.45%	91
2015 Q4	–	Sell	-70,367	Closed	-$1.54M	–	91
2015 Q3	$1.54M	Sell	70,367 -8,088	-10%	-$202K	1.39%	31
2015 Q2	$1.93M	Buy	+78,455	New	+$1.75M	1.39%	31

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Lisanti Capital Growth's ATRC Position: Q4 2021 in Review

Lisanti Capital Growth sold out of AtriCure (ATRC) in Q4 2021, closing a stake of 26,610 shares — an estimated $1.85M sold.

Lisanti Capital Growth first reported a position in ATRC in Q2 2015 and held it in 7 quarters. The position peaked at $6.09M in Q2 2020. 217 funds tracked by Wall St. Rank hold ATRC as of Q4 2021.

Lisanti Capital Growth reported no remaining AtriCure position as of Q4 2021 after selling out during the quarter.
Lisanti Capital Growth sold 26,610 AtriCure shares in Q4 2021, an estimated $1.85M.
Lisanti Capital Growth first reported a position in AtriCure in Q2 2015 and held it in 7 quarters.
Lisanti Capital Growth's AtriCure position peaked at $6.09M in Q2 2020.
217 funds tracked by Wall St. Rank held AtriCure as of Q4 2021.

Based on Lisanti Capital Growth's 13F filing for Q4 2021, filed 4 Feb 2022.